What's New

News

2016/09/30
Updated information of CSR
2016/07/05
Results of Phase III study of NK105, a novel macromolecular micelle encapsulating an anticancer drug
2016/06/08
Announcement: Establishment of Joint Venture Company for MAB Production
2016/06/06
Notice Concerning Monthly Share Repurchase Results and Repurchase Completion
2016/06/05
The 100th anniversary of the Nippon Kayaku Group’s founding is on June 5, 2016.
2016/04/27
Nippon Kayaku Announces FDA Orphan Drug Designation to New Polymeric micelle Anti-Cancer Drug NK012 for Small Cell Lung Cancer
2016/03/30
We have published "Nippon Kayaku Commemorating 100 Years of Sukima Ideas".
PageTop
Corporate Vision
Our Business
Corporate Information
Global Netowork
Investor Relations
CSR